Ticagrelor in Patients With ST Elevation Myocardial Infarction Treated With Pharmacological Thrombolysis

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 3799 participants.

Also called NCT02298088

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 3,799 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02298088
Other papers using this trial's data
  • Morphine and clinical outcomes in patients with ST segment elevation myocardial infarction treated with fibrinolytic and antiplatelet therapy: Insights from the TREAT trial American heart journal, 2022-09 DOI, PubMed 35533724
  • Ticagrelor Versus Clopidogrel in Patients With STEMI Treated With Fibrinolysis: TREAT Trial Journal of the American College of Cardiology, 2019-06-11 DOI, PubMed 30898608
  • Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical Trial JAMA cardiology, 2018-05-01 DOI, PubMed 29525822, PMC5875327 PubMed links an erratum for this paper. Erratum: PMID 29800134 Not in the PMC Open Access subset.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Argentina, Australia, Brazil, Canada, China, Colombia, New Zealand, Peru, Russia, Ukraine (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02298088. Randomized; no masking; primary purpose treatment. Start 2015-08 (actual); primary completion 2017-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Ticagrelor in Patients With ST Elevation Myocardial Infarction Treated With Pharmacological Thrombolysis
Acronym
TREAT
Condition
Acute ST Segment Elevation Myocardial Infarction
Condition
Thrombolysis in Myocardial Infarction Flow
Intervention (Drug)
Ticagrelor 180 mg
Intervention (Drug)
Clopidogrel
Lead sponsor
Hospital do Coracao (class: other)

Record details

Record id
cardio:ct-nct02298088
Content hash
ad9571e2d6d55a9d25003d63640db5926fca6446abc332dca3e9b67e5204cc9f